Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 56 | 2023 | 839 | 7.620 |
Why?
|
Vagina | 20 | 2020 | 825 | 3.810 |
Why?
|
Pelvic Pain | 27 | 2023 | 274 | 3.010 |
Why?
|
Uterus | 16 | 2013 | 711 | 2.950 |
Why?
|
Laparoscopy | 22 | 2023 | 2151 | 1.620 |
Why?
|
Norethindrone | 7 | 2018 | 59 | 1.570 |
Why?
|
Peritoneal Diseases | 4 | 2021 | 75 | 1.550 |
Why?
|
Mullerian Ducts | 9 | 2020 | 198 | 1.490 |
Why?
|
Gonadotropin-Releasing Hormone | 13 | 2023 | 1205 | 1.260 |
Why?
|
Ovarian Diseases | 6 | 2016 | 139 | 1.140 |
Why?
|
Abnormalities, Multiple | 5 | 2020 | 1416 | 1.100 |
Why?
|
Gynecology | 4 | 2021 | 513 | 0.990 |
Why?
|
Ovary | 7 | 2009 | 981 | 0.930 |
Why?
|
Dysmenorrhea | 8 | 2023 | 86 | 0.910 |
Why?
|
Gynecologic Surgical Procedures | 9 | 2011 | 336 | 0.840 |
Why?
|
Infertility, Female | 7 | 2019 | 787 | 0.810 |
Why?
|
Vaginal Fistula | 2 | 2020 | 18 | 0.810 |
Why?
|
Adolescent | 89 | 2023 | 85781 | 0.800 |
Why?
|
Menarche | 3 | 2010 | 516 | 0.790 |
Why?
|
Vaginal Diseases | 3 | 2013 | 102 | 0.780 |
Why?
|
Cervix Uteri | 5 | 2011 | 590 | 0.740 |
Why?
|
Uterine Cervical Diseases | 1 | 2020 | 77 | 0.740 |
Why?
|
Vulvar Diseases | 4 | 2009 | 61 | 0.720 |
Why?
|
Ovarian Neoplasms | 10 | 2021 | 4838 | 0.710 |
Why?
|
Contraceptives, Oral, Hormonal | 3 | 2016 | 188 | 0.700 |
Why?
|
Fistula | 1 | 2020 | 220 | 0.660 |
Why?
|
Tissue Adhesions | 2 | 2019 | 235 | 0.650 |
Why?
|
Menorrhagia | 1 | 2018 | 63 | 0.640 |
Why?
|
Vulvar Neoplasms | 4 | 2018 | 272 | 0.640 |
Why?
|
Kidney | 5 | 2020 | 7186 | 0.630 |
Why?
|
Vaginal Neoplasms | 1 | 2018 | 106 | 0.620 |
Why?
|
Surgically-Created Structures | 2 | 2007 | 10 | 0.620 |
Why?
|
Granular Cell Tumor | 1 | 2018 | 51 | 0.610 |
Why?
|
Ureter | 1 | 2020 | 375 | 0.610 |
Why?
|
Uterine Neoplasms | 2 | 2021 | 1513 | 0.610 |
Why?
|
Leuprolide | 7 | 2018 | 321 | 0.600 |
Why?
|
Foreign Bodies | 1 | 2021 | 399 | 0.580 |
Why?
|
Genitalia, Female | 4 | 1999 | 146 | 0.580 |
Why?
|
Amenorrhea | 6 | 2015 | 485 | 0.570 |
Why?
|
Vulva | 3 | 2018 | 87 | 0.560 |
Why?
|
Urinary Bladder Diseases | 1 | 2017 | 166 | 0.560 |
Why?
|
Fallopian Tube Diseases | 2 | 2011 | 62 | 0.560 |
Why?
|
Burkitt Lymphoma | 1 | 2018 | 327 | 0.550 |
Why?
|
Female | 131 | 2023 | 380194 | 0.550 |
Why?
|
Contraceptives, Oral, Synthetic | 3 | 2016 | 16 | 0.540 |
Why?
|
Endometrium | 4 | 2021 | 424 | 0.520 |
Why?
|
Torsion Abnormality | 4 | 2011 | 93 | 0.480 |
Why?
|
Hematocolpos | 1 | 2013 | 6 | 0.460 |
Why?
|
Pelvic Inflammatory Disease | 5 | 2000 | 94 | 0.460 |
Why?
|
Uterine Hemorrhage | 4 | 2021 | 255 | 0.450 |
Why?
|
Hymen | 3 | 2009 | 16 | 0.430 |
Why?
|
Syndrome | 8 | 2020 | 3251 | 0.430 |
Why?
|
Ovulation Inhibition | 1 | 2011 | 4 | 0.410 |
Why?
|
Limb Deformities, Congenital | 1 | 2013 | 136 | 0.410 |
Why?
|
Metrorrhagia | 1 | 2011 | 18 | 0.410 |
Why?
|
Hormone Antagonists | 1 | 2011 | 108 | 0.390 |
Why?
|
Humans | 132 | 2023 | 744343 | 0.380 |
Why?
|
Dyspareunia | 2 | 2022 | 50 | 0.380 |
Why?
|
Superinfection | 1 | 2010 | 65 | 0.380 |
Why?
|
Dermoid Cyst | 1 | 2010 | 93 | 0.360 |
Why?
|
Focal Dermal Hypoplasia | 1 | 2009 | 8 | 0.360 |
Why?
|
Child | 42 | 2021 | 77709 | 0.360 |
Why?
|
Acupuncture Therapy | 3 | 2009 | 464 | 0.350 |
Why?
|
Ovarian Cysts | 3 | 2010 | 115 | 0.350 |
Why?
|
Urogenital Surgical Procedures | 1 | 2009 | 35 | 0.340 |
Why?
|
Kidney Diseases | 1 | 2020 | 2149 | 0.340 |
Why?
|
Menstrual Cycle | 3 | 2020 | 551 | 0.330 |
Why?
|
Cystadenoma, Serous | 1 | 2009 | 102 | 0.330 |
Why?
|
Thrombocytosis | 1 | 2008 | 81 | 0.320 |
Why?
|
Coloring Agents | 1 | 2011 | 566 | 0.320 |
Why?
|
Dilatation | 1 | 2009 | 291 | 0.320 |
Why?
|
Perineum | 1 | 2009 | 211 | 0.310 |
Why?
|
Ascitic Fluid | 2 | 2020 | 192 | 0.310 |
Why?
|
Puberty | 2 | 2009 | 490 | 0.310 |
Why?
|
Uterine Diseases | 1 | 2009 | 135 | 0.310 |
Why?
|
Attitude of Health Personnel | 2 | 2011 | 3843 | 0.300 |
Why?
|
Progesterone | 4 | 2010 | 776 | 0.300 |
Why?
|
Fallopian Tubes | 1 | 2008 | 182 | 0.300 |
Why?
|
Diseases in Twins | 1 | 2009 | 449 | 0.300 |
Why?
|
Axilla | 1 | 2009 | 595 | 0.300 |
Why?
|
Young Adult | 31 | 2023 | 56430 | 0.290 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2007 | 115 | 0.290 |
Why?
|
Estrogens, Conjugated (USP) | 3 | 2018 | 275 | 0.290 |
Why?
|
Wilms Tumor | 1 | 2009 | 373 | 0.290 |
Why?
|
Ultrasonography | 8 | 2021 | 5985 | 0.280 |
Why?
|
Quality of Life | 9 | 2022 | 12804 | 0.270 |
Why?
|
Adenoma | 1 | 2016 | 2174 | 0.270 |
Why?
|
Diagnostic Errors | 3 | 2019 | 1257 | 0.270 |
Why?
|
Saliva | 1 | 2010 | 809 | 0.270 |
Why?
|
Uterine Prolapse | 1 | 2006 | 73 | 0.270 |
Why?
|
Ovariectomy | 4 | 2019 | 661 | 0.260 |
Why?
|
Leiomyoma | 1 | 2011 | 730 | 0.260 |
Why?
|
Vulvar Lichen Sclerosus | 2 | 2007 | 11 | 0.260 |
Why?
|
Urogenital Abnormalities | 1 | 2008 | 261 | 0.250 |
Why?
|
Congenital Abnormalities | 3 | 2020 | 707 | 0.250 |
Why?
|
Prolactin | 3 | 1997 | 669 | 0.250 |
Why?
|
Meningomyelocele | 1 | 2006 | 165 | 0.250 |
Why?
|
Bone Density | 6 | 2015 | 3468 | 0.240 |
Why?
|
Hematoma | 1 | 2009 | 758 | 0.240 |
Why?
|
Appendicitis | 1 | 2010 | 645 | 0.240 |
Why?
|
Fertility | 3 | 2011 | 781 | 0.230 |
Why?
|
Catheterization | 1 | 2009 | 1470 | 0.230 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 4266 | 0.230 |
Why?
|
Abortion, Habitual | 3 | 2009 | 70 | 0.230 |
Why?
|
Progestins | 3 | 2023 | 306 | 0.220 |
Why?
|
Adult | 46 | 2023 | 214055 | 0.220 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 12959 | 0.210 |
Why?
|
Skin Transplantation | 1 | 2007 | 1074 | 0.210 |
Why?
|
Counseling | 1 | 2010 | 1523 | 0.200 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1400 | 0.200 |
Why?
|
Fertility Agents, Female | 2 | 2013 | 99 | 0.200 |
Why?
|
Thyrotropin | 2 | 1995 | 849 | 0.190 |
Why?
|
Adnexal Diseases | 1 | 2002 | 102 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4253 | 0.190 |
Why?
|
Preoperative Care | 4 | 2019 | 2250 | 0.190 |
Why?
|
Tissue Scaffolds | 1 | 2007 | 956 | 0.190 |
Why?
|
Cellulose, Oxidized | 1 | 2000 | 12 | 0.180 |
Why?
|
Pelvis | 3 | 2022 | 730 | 0.180 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2020 | 31 | 0.180 |
Why?
|
Retrospective Studies | 24 | 2023 | 77449 | 0.180 |
Why?
|
Patient Compliance | 1 | 2010 | 2684 | 0.180 |
Why?
|
Lichen Sclerosus et Atrophicus | 1 | 2000 | 28 | 0.180 |
Why?
|
Dysgerminoma | 1 | 1999 | 65 | 0.180 |
Why?
|
Medical Illustration | 1 | 2020 | 133 | 0.180 |
Why?
|
Contraceptives, Oral, Combined | 3 | 2023 | 113 | 0.180 |
Why?
|
Sexual Abstinence | 1 | 1999 | 16 | 0.180 |
Why?
|
Forensic Medicine | 1 | 1999 | 64 | 0.170 |
Why?
|
Mastocytosis, Systemic | 1 | 2021 | 100 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2018 | 9239 | 0.170 |
Why?
|
Women's Health | 1 | 2008 | 2034 | 0.170 |
Why?
|
Pregnancy Tests | 1 | 1998 | 30 | 0.160 |
Why?
|
Fetal Diseases | 1 | 2004 | 903 | 0.160 |
Why?
|
Child, Preschool | 14 | 2021 | 41006 | 0.160 |
Why?
|
CA-125 Antigen | 1 | 2020 | 286 | 0.160 |
Why?
|
Health Personnel | 1 | 2011 | 3218 | 0.160 |
Why?
|
Peritoneum | 1 | 2019 | 228 | 0.150 |
Why?
|
Contraceptives, Oral | 4 | 2007 | 564 | 0.150 |
Why?
|
Genital Diseases, Female | 1 | 1999 | 197 | 0.150 |
Why?
|
Physical Examination | 3 | 2011 | 1237 | 0.150 |
Why?
|
Estrogens | 5 | 2016 | 1566 | 0.150 |
Why?
|
Child Abuse, Sexual | 1 | 1999 | 383 | 0.150 |
Why?
|
Prenatal Diagnosis | 1 | 2004 | 1236 | 0.140 |
Why?
|
Disease Progression | 2 | 2010 | 13284 | 0.140 |
Why?
|
Cystoscopy | 1 | 2017 | 134 | 0.140 |
Why?
|
Pregnancy in Adolescence | 1 | 1998 | 158 | 0.140 |
Why?
|
Menstruation | 2 | 2009 | 302 | 0.140 |
Why?
|
Pregnancy Outcome | 4 | 2009 | 2795 | 0.140 |
Why?
|
Cyclophosphamide | 2 | 2001 | 2242 | 0.140 |
Why?
|
Ethinyl Estradiol | 1 | 2016 | 116 | 0.140 |
Why?
|
Medical History Taking | 3 | 2014 | 783 | 0.140 |
Why?
|
Heart Defects, Congenital | 1 | 2013 | 4584 | 0.140 |
Why?
|
Age Factors | 6 | 2021 | 18370 | 0.130 |
Why?
|
Puberty, Precocious | 1 | 1997 | 156 | 0.130 |
Why?
|
Adnexa Uteri | 2 | 2007 | 45 | 0.130 |
Why?
|
Pain | 5 | 2023 | 4986 | 0.130 |
Why?
|
Delayed Diagnosis | 4 | 2019 | 441 | 0.130 |
Why?
|
Conscious Sedation | 1 | 1999 | 528 | 0.120 |
Why?
|
Fertilization in Vitro | 2 | 2010 | 1284 | 0.120 |
Why?
|
Menstruation Disturbances | 2 | 2006 | 148 | 0.120 |
Why?
|
Self Concept | 1 | 2020 | 1025 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2020 | 816 | 0.120 |
Why?
|
Bone Marrow Transplantation | 2 | 2003 | 2765 | 0.120 |
Why?
|
Pregnancy | 10 | 2021 | 29144 | 0.120 |
Why?
|
Follicle Stimulating Hormone | 2 | 2001 | 744 | 0.120 |
Why?
|
Nausea | 2 | 2017 | 673 | 0.110 |
Why?
|
Treatment Outcome | 14 | 2020 | 63114 | 0.110 |
Why?
|
Spine | 2 | 2013 | 1144 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2015 | 324 | 0.110 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4262 | 0.110 |
Why?
|
Pediatric Assistants | 1 | 2011 | 8 | 0.110 |
Why?
|
Fetal Heart | 1 | 1994 | 276 | 0.110 |
Why?
|
Boston | 7 | 2021 | 9313 | 0.100 |
Why?
|
Hypothyroidism | 1 | 1997 | 658 | 0.100 |
Why?
|
Cytodiagnosis | 1 | 2015 | 435 | 0.100 |
Why?
|
Salpingectomy | 1 | 2011 | 53 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 7 | 2019 | 35421 | 0.100 |
Why?
|
Platelet Count | 2 | 2008 | 781 | 0.100 |
Why?
|
Shock, Septic | 1 | 1997 | 775 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5442 | 0.090 |
Why?
|
Leukocytosis | 1 | 2011 | 247 | 0.090 |
Why?
|
Skin Diseases | 1 | 1999 | 1065 | 0.090 |
Why?
|
Testosterone | 2 | 2020 | 2420 | 0.090 |
Why?
|
Anal Canal | 1 | 2013 | 376 | 0.090 |
Why?
|
Hypertrophy | 2 | 2009 | 569 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39050 | 0.090 |
Why?
|
Acupuncture Points | 1 | 2009 | 101 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2282 | 0.090 |
Why?
|
Tachycardia | 1 | 2011 | 619 | 0.090 |
Why?
|
Electrocoagulation | 1 | 2009 | 158 | 0.080 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2009 | 162 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2014 | 824 | 0.080 |
Why?
|
Vomiting | 1 | 2011 | 636 | 0.080 |
Why?
|
Metaplasia | 1 | 2009 | 313 | 0.080 |
Why?
|
Lasers, Gas | 1 | 2009 | 93 | 0.080 |
Why?
|
Galvanic Skin Response | 1 | 2009 | 349 | 0.080 |
Why?
|
Twins, Monozygotic | 1 | 2009 | 458 | 0.080 |
Why?
|
Stress, Psychological | 2 | 2021 | 4245 | 0.080 |
Why?
|
Infant | 7 | 2021 | 35136 | 0.080 |
Why?
|
Inflammation | 2 | 2020 | 10638 | 0.080 |
Why?
|
Time Factors | 5 | 2018 | 40075 | 0.070 |
Why?
|
Guided Tissue Regeneration | 1 | 2007 | 85 | 0.070 |
Why?
|
Body Size | 1 | 2010 | 461 | 0.070 |
Why?
|
Dermatitis | 2 | 1999 | 197 | 0.070 |
Why?
|
Trachea | 1 | 2013 | 1076 | 0.070 |
Why?
|
Esophagus | 1 | 2013 | 1019 | 0.070 |
Why?
|
Organogenesis | 1 | 2008 | 222 | 0.070 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8863 | 0.070 |
Why?
|
Physician-Patient Relations | 3 | 2010 | 3229 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 1 | 1994 | 1695 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2018 | 1620 | 0.070 |
Why?
|
Cytokines | 1 | 2020 | 7322 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1584 | 0.070 |
Why?
|
Chronic Disease | 4 | 2023 | 9146 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3712 | 0.060 |
Why?
|
Biopsy | 3 | 2021 | 6756 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 950 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2124 | 0.060 |
Why?
|
Pain Measurement | 3 | 2009 | 3420 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1770 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2021 | 25625 | 0.060 |
Why?
|
Robotics | 1 | 2011 | 899 | 0.060 |
Why?
|
Pediatrics | 1 | 1998 | 3475 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1405 | 0.060 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2002 | 16 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.050 |
Why?
|
Cystectomy | 1 | 2008 | 686 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2011 | 1018 | 0.050 |
Why?
|
Mass Screening | 1 | 1998 | 5255 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2010 | 1451 | 0.050 |
Why?
|
Thyroxine | 2 | 1997 | 667 | 0.050 |
Why?
|
Laparotomy | 1 | 2004 | 473 | 0.050 |
Why?
|
Weight Gain | 1 | 2011 | 2292 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2009 | 8642 | 0.050 |
Why?
|
Estradiol | 2 | 1997 | 2020 | 0.050 |
Why?
|
Accidental Falls | 1 | 2009 | 1062 | 0.050 |
Why?
|
Reoperation | 1 | 2011 | 4201 | 0.050 |
Why?
|
Genitalia, Male | 1 | 2001 | 84 | 0.050 |
Why?
|
Danazol | 1 | 2020 | 42 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 7913 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2016 | 6489 | 0.050 |
Why?
|
Ovarian Follicle | 1 | 2002 | 247 | 0.050 |
Why?
|
Hysterectomy | 2 | 2019 | 927 | 0.050 |
Why?
|
Incidence | 2 | 2009 | 20947 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2007 | 1180 | 0.050 |
Why?
|
Clitoris | 1 | 2000 | 33 | 0.050 |
Why?
|
Registries | 2 | 2014 | 8089 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2017 | 11483 | 0.040 |
Why?
|
Epithelium | 2 | 2021 | 1679 | 0.040 |
Why?
|
Skin Diseases, Papulosquamous | 1 | 1999 | 18 | 0.040 |
Why?
|
Skin Diseases, Viral | 1 | 1999 | 21 | 0.040 |
Why?
|
Vulvitis | 1 | 1998 | 8 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2020 | 537 | 0.040 |
Why?
|
Recurrence | 3 | 2006 | 8340 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2007 | 4776 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3309 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2019 | 152 | 0.040 |
Why?
|
Medical Records | 2 | 2002 | 1413 | 0.040 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 1999 | 85 | 0.040 |
Why?
|
Regional Blood Flow | 1 | 2002 | 1525 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 25043 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2018 | 13989 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4215 | 0.040 |
Why?
|
Denervation | 1 | 2019 | 278 | 0.040 |
Why?
|
Periodicity | 1 | 1999 | 363 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 21746 | 0.040 |
Why?
|
Adolescent Medicine | 1 | 1998 | 72 | 0.040 |
Why?
|
Infertility, Male | 1 | 2001 | 409 | 0.040 |
Why?
|
Isotonic Solutions | 1 | 1997 | 119 | 0.040 |
Why?
|
Age Distribution | 2 | 2018 | 2902 | 0.040 |
Why?
|
Comorbidity | 2 | 2023 | 10388 | 0.040 |
Why?
|
Adolescent Health Services | 1 | 1999 | 215 | 0.040 |
Why?
|
Embryoid Bodies | 1 | 2017 | 67 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.040 |
Why?
|
Arteries | 1 | 2002 | 1119 | 0.040 |
Why?
|
Primary Health Care | 1 | 2013 | 4558 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14722 | 0.040 |
Why?
|
Thrombosis | 1 | 2011 | 2968 | 0.040 |
Why?
|
Prospective Studies | 4 | 2015 | 53288 | 0.040 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2001 | 627 | 0.040 |
Why?
|
Hospitals, Pediatric | 2 | 2016 | 1775 | 0.040 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 1997 | 53 | 0.040 |
Why?
|
Thyroiditis, Autoimmune | 1 | 1997 | 101 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 386 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 188 | 0.040 |
Why?
|
Abdominal Abscess | 1 | 1998 | 154 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 1998 | 477 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 670 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 1997 | 301 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 1997 | 552 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2004 | 3479 | 0.030 |
Why?
|
Absorptiometry, Photon | 2 | 2015 | 1725 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2052 | 0.030 |
Why?
|
Goserelin | 1 | 2015 | 129 | 0.030 |
Why?
|
Postoperative Complications | 1 | 1997 | 15295 | 0.030 |
Why?
|
Gonadal Dysgenesis | 1 | 1994 | 30 | 0.030 |
Why?
|
Sodium Chloride | 1 | 1997 | 625 | 0.030 |
Why?
|
United States | 4 | 2021 | 69872 | 0.030 |
Why?
|
Middle Aged | 8 | 2021 | 213383 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1420 | 0.030 |
Why?
|
Bradycardia | 1 | 1997 | 307 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 550 | 0.030 |
Why?
|
Risk Factors | 6 | 2020 | 72290 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2015 | 155 | 0.030 |
Why?
|
Ovulation | 1 | 1995 | 189 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2021 | 1598 | 0.030 |
Why?
|
Disorders of Sex Development | 1 | 1994 | 122 | 0.030 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 135 | 0.030 |
Why?
|
Clomiphene | 1 | 1993 | 72 | 0.030 |
Why?
|
Dilatation and Curettage | 1 | 1993 | 56 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2008 | 15076 | 0.030 |
Why?
|
Prognosis | 3 | 2013 | 29063 | 0.030 |
Why?
|
Reticulocytes | 1 | 1994 | 290 | 0.030 |
Why?
|
Triiodothyronine | 1 | 1995 | 494 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1997 | 1850 | 0.030 |
Why?
|
Social Stigma | 1 | 2019 | 701 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2011 | 19905 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7181 | 0.030 |
Why?
|
Abortion, Induced | 1 | 1998 | 458 | 0.030 |
Why?
|
Glycoproteins | 1 | 1980 | 2263 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2959 | 0.030 |
Why?
|
Mood Disorders | 1 | 2018 | 1106 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1643 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2016 | 12026 | 0.030 |
Why?
|
Critical Pathways | 1 | 1995 | 476 | 0.030 |
Why?
|
Bone Resorption | 1 | 2015 | 723 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 1998 | 1203 | 0.020 |
Why?
|
Progesterone Congeners | 1 | 2011 | 42 | 0.020 |
Why?
|
Education | 1 | 2014 | 543 | 0.020 |
Why?
|
Drainage | 1 | 1997 | 1142 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 2957 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 23338 | 0.020 |
Why?
|
Fetal Death | 1 | 1993 | 448 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3305 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2118 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1993 | 498 | 0.020 |
Why?
|
Sarcoma | 1 | 2001 | 1897 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3558 | 0.020 |
Why?
|
Leukemia | 1 | 1997 | 1511 | 0.020 |
Why?
|
Survivors | 1 | 1999 | 2291 | 0.020 |
Why?
|
Postmenopause | 1 | 1998 | 2461 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1003 | 0.020 |
Why?
|
Acute Disease | 1 | 1999 | 7149 | 0.020 |
Why?
|
Lymphoma | 1 | 1997 | 1877 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1184 | 0.020 |
Why?
|
Hemoglobins | 1 | 1994 | 1534 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1993 | 1375 | 0.020 |
Why?
|
Cohort Studies | 3 | 2022 | 40561 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2010 | 302 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 1999 | 1917 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 1999 | 1876 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1993 | 1462 | 0.020 |
Why?
|
Reference Values | 1 | 1995 | 4982 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3507 | 0.020 |
Why?
|
Androgens | 1 | 1994 | 1281 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2009 | 6365 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 19229 | 0.020 |
Why?
|
Thinness | 1 | 2010 | 480 | 0.020 |
Why?
|
Life Style | 1 | 1998 | 3835 | 0.020 |
Why?
|
Hip | 1 | 2007 | 257 | 0.020 |
Why?
|
Health Behavior | 1 | 1998 | 2636 | 0.020 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2007 | 233 | 0.020 |
Why?
|
Communication | 1 | 1999 | 3749 | 0.020 |
Why?
|
Placebos | 1 | 2009 | 1676 | 0.020 |
Why?
|
Pilot Projects | 1 | 1997 | 8324 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12261 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15540 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5319 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15997 | 0.010 |
Why?
|
Drug Compounding | 1 | 2003 | 242 | 0.010 |
Why?
|
Administration, Topical | 1 | 2003 | 690 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2645 | 0.010 |
Why?
|
Autopsy | 1 | 2005 | 1020 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 17446 | 0.010 |
Why?
|
Periodic Acid-Schiff Reaction | 1 | 1980 | 15 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
Cyclosporine | 1 | 2003 | 786 | 0.010 |
Why?
|
Observer Variation | 1 | 2007 | 2593 | 0.010 |
Why?
|
Castration | 1 | 1980 | 159 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2005 | 1097 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1998 | 5256 | 0.010 |
Why?
|
Male | 4 | 2021 | 350118 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
Acetylglucosamine | 1 | 1980 | 191 | 0.010 |
Why?
|
Leucine | 1 | 1980 | 561 | 0.010 |
Why?
|
Overweight | 1 | 2010 | 2371 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2001 | 869 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2007 | 1848 | 0.010 |
Why?
|
Aged | 2 | 2020 | 163280 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5391 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2005 | 2187 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2004 | 20822 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16365 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2418 | 0.010 |
Why?
|
Menopause | 1 | 2004 | 1626 | 0.010 |
Why?
|
Immunosuppressive Agents | 2 | 2003 | 4149 | 0.010 |
Why?
|
Necrosis | 1 | 2000 | 1643 | 0.010 |
Why?
|
Animals | 4 | 2017 | 168757 | 0.010 |
Why?
|
Adolescent, Hospitalized | 1 | 1995 | 31 | 0.010 |
Why?
|
Suture Techniques | 1 | 2000 | 798 | 0.010 |
Why?
|
Forms and Records Control | 1 | 1995 | 160 | 0.010 |
Why?
|
Cell Separation | 1 | 1980 | 1751 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2886 | 0.010 |
Why?
|
Rabbits | 1 | 1980 | 4894 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2000 | 3508 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81183 | 0.010 |
Why?
|
Risk | 1 | 2004 | 9687 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12720 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11366 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1993 | 514 | 0.010 |
Why?
|
Blastocyst | 1 | 1993 | 424 | 0.010 |
Why?
|
Logistic Models | 1 | 2004 | 13408 | 0.010 |
Why?
|
Biological Assay | 1 | 1993 | 652 | 0.010 |
Why?
|
Pregnancy Trimester, First | 1 | 1993 | 853 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1980 | 3690 | 0.000 |
Why?
|
Length of Stay | 1 | 2000 | 6309 | 0.000 |
Why?
|
Chromosome Aberrations | 1 | 1993 | 1813 | 0.000 |
Why?
|
Cost of Illness | 1 | 1995 | 1859 | 0.000 |
Why?
|
Hospitalization | 1 | 2000 | 10262 | 0.000 |
Why?
|